Researchers might've discovered an anti-inflammatory drug that could cut down heart attack risks
Source : NewsBharatiDate : 29-Aug-2017
London, August 29: A heart attack is a serious medical emergency in which the supply of blood to the heart is suddenly blocked. Researchers from years are trying to break the ice for ‘heart attack’ treatments. And to our surprise, there is one institution that might’ve found the treatment to heart attack. The British Heart Foundation said they could help lives with the help of drug called ‘canakinumab’. BHF performed a study where patients reported 15% reduction in the risk of repeat heart attacks.
Heart attack patients are routinely given cholesterol-lowering statins and blood-thinning drugs to help reduce the risk of repeat attacks. In this study, 10,000 patients who had previously had a heart attack were treated with the anti-inflammatory drug once every three months.` The trial, held in almost 40 countries, monitored the individuals for up to four years. It found what researchers said were reductions in risk "above and beyond" those seen in patients who only took statins. However, it also found a "significantly higher incidence" of potentially fatal infection and sepsis among those treated with the drug, according to the study.
Canakinumab was initially developed by pharmaceutical firm Novartis - which paid for the trial - to treat rheumatoid arthritis.
Prof Jeremy Pearson, associate medical director at the BHF, said: "The findings suggest that existing anti-inflammatory drugs, such as canakinumab, could be given along with cholesterol-lowering drugs to treat survivors and further reduce their risk of another heart attack." Gary Gibbons, director of the National Heart, Lung, and Blood Institute, said the findings provided "compelling evidence". He called for further research into the findings.
If successful, it’ll prove as the greatest breakthrough in the field of medical science.